75 STATE STREET, BOSTON, MA
To File Registration Statement with the SEC Regarding Proposed Transaction with
Enters into Licensing Agreement to Develop and Commercialize Navenibart for HAE in Japan
Material disclosure
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Presentation January 2025
2022 Inducement Stock Incentive Plan
Q2
FY 2024
Q3
Q1
FY 2023
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership